Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Mauri

Showing results (201-210 of 335) with videos related to

Pageof 34
Sort By:
The American Journal of Cardiology|October 27, 2019
Interruption of Dual Antiplatelet Therapy Within Six Months After Coronary Stents (from the Dual Antiplatelet Therapy Study)Ada C Stefanescu Schmidt, Philippe Gabriel Steg, Robert W Yeh, et al.
JACC. Cardiovascular Interventions|November 14, 2016
Use and Effectiveness of Bivalirudin Versus Unfractionated Heparin for Percutaneous Coronary Intervention Among Patients With ST-Segment Elevation Myocardial Infarction in the United StatesEric A Secemsky, Ajay Kirtane, Sripal Bangalore, et al.
Circulation|September 30, 2015
Response to letters regarding article, "prasugrel plus aspirin beyond 12 months is associated with improved outcomes after TAXUS Liberté paclitaxel-eluting coronary stent placement"Kirk N Garratt, W Douglas Weaver, Ronald G Jenkins, et al.
Circulation. Cardiovascular Quality and Outcomes|August 20, 2015
Enhancing the Prediction of 30-Day Readmission After Percutaneous Coronary Intervention Using Data Extracted by Querying of the Electronic Health RecordJason H Wasfy, Gaurav Singal, Cashel O'Brien, et al.
Circulation. Cardiovascular Interventions|April 10, 2016
Effectiveness of Arterial Closure Devices for Preventing Complications With Percutaneous Coronary Intervention: An Instrumental Variable AnalysisNeil J Wimmer, Eric A Secemsky, Laura Mauri, et al.
The American Journal of Cardiology|May 10, 2005
Comparison of thrombosis and restenosis risk from stent length of sirolimus-eluting stents versus bare metal stentsLaura Mauri, A James O'Malley, Jeffrey J Popma, et al.
Glycoconjugate Journal|November 29, 2007
Involvement of very long fatty acid-containing lactosylceramide in lactosylceramide-mediated superoxide generation and migration in neutrophilsKazuhisa Iwabuchi, Alessandro Prinetti, Sandro Sonnino, et al.
The American Journal of Cardiology|September 7, 2010
Effect of coronary target lesion revascularization on late cardiac events after insertion of sirolimus-eluting or bare metal stentsVictor Novack, Michael C Nguyen, Meredith Rooney, et al.
JACC. Cardiovascular Interventions|May 26, 2009
A novel filter-based distal embolic protection device for percutaneous intervention of saphenous vein graft lesions: results of the AMEthyst randomized controlled trialDean J Kereiakes, Mark A Turco, Jeffrey Breall, et al.
Circulation. Cardiovascular Interventions|January 10, 2018
Impact of Clopidogrel Therapy on Mortality and Cancer in Patients With Cardiovascular and Cerebrovascular Disease: A Patient-Level Meta-AnalysisSammy Elmariah, Gheorghe Doros, Oscar R Benavente, et al.
Pageof 34

Showing results (201-210 of 335) with videos related to

Sort By:
Pageof 34
The American Journal of Cardiology|October 27, 2019
Interruption of Dual Antiplatelet Therapy Within Six Months After Coronary Stents (from the Dual Antiplatelet Therapy Study)Ada C Stefanescu Schmidt, Philippe Gabriel Steg, Robert W Yeh, et al.
JACC. Cardiovascular Interventions|November 14, 2016
Use and Effectiveness of Bivalirudin Versus Unfractionated Heparin for Percutaneous Coronary Intervention Among Patients With ST-Segment Elevation Myocardial Infarction in the United StatesEric A Secemsky, Ajay Kirtane, Sripal Bangalore, et al.
Circulation|September 30, 2015
Response to letters regarding article, "prasugrel plus aspirin beyond 12 months is associated with improved outcomes after TAXUS Liberté paclitaxel-eluting coronary stent placement"Kirk N Garratt, W Douglas Weaver, Ronald G Jenkins, et al.
Circulation. Cardiovascular Quality and Outcomes|August 20, 2015
Enhancing the Prediction of 30-Day Readmission After Percutaneous Coronary Intervention Using Data Extracted by Querying of the Electronic Health RecordJason H Wasfy, Gaurav Singal, Cashel O'Brien, et al.
Circulation. Cardiovascular Interventions|April 10, 2016
Effectiveness of Arterial Closure Devices for Preventing Complications With Percutaneous Coronary Intervention: An Instrumental Variable AnalysisNeil J Wimmer, Eric A Secemsky, Laura Mauri, et al.
The American Journal of Cardiology|May 10, 2005
Comparison of thrombosis and restenosis risk from stent length of sirolimus-eluting stents versus bare metal stentsLaura Mauri, A James O'Malley, Jeffrey J Popma, et al.
Glycoconjugate Journal|November 29, 2007
Involvement of very long fatty acid-containing lactosylceramide in lactosylceramide-mediated superoxide generation and migration in neutrophilsKazuhisa Iwabuchi, Alessandro Prinetti, Sandro Sonnino, et al.
The American Journal of Cardiology|September 7, 2010
Effect of coronary target lesion revascularization on late cardiac events after insertion of sirolimus-eluting or bare metal stentsVictor Novack, Michael C Nguyen, Meredith Rooney, et al.
JACC. Cardiovascular Interventions|May 26, 2009
A novel filter-based distal embolic protection device for percutaneous intervention of saphenous vein graft lesions: results of the AMEthyst randomized controlled trialDean J Kereiakes, Mark A Turco, Jeffrey Breall, et al.
Circulation. Cardiovascular Interventions|January 10, 2018
Impact of Clopidogrel Therapy on Mortality and Cancer in Patients With Cardiovascular and Cerebrovascular Disease: A Patient-Level Meta-AnalysisSammy Elmariah, Gheorghe Doros, Oscar R Benavente, et al.
Pageof 34